CENGILD logo

Cengild Medical Berhad Stock Price

KLSE:CENGILD Community·RM 174.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CENGILD Share Price Performance

RM 0
-0.25 (-100.00%)
RM 0
-0.25 (-100.00%)
Price RM 0

CENGILD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
1 Reward

Cengild Medical Berhad Key Details

RM 74.9m

Revenue

RM 40.1m

Cost of Revenue

RM 34.8m

Gross Profit

RM 23.7m

Other Expenses

RM 11.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.013
46.43%
14.85%
67.7%
View Full Analysis

About CENGILD

Founded
2017
Employees
151
CEO
Wai Lee
WebsiteView website
cengild.com

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy. It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; operating theatre, endoscopy, radiology and imaging services; accident and emergency care, and health screenings; and consultant services. Cengild Medical Berhad was founded in 2017 and is based in Kuala Lumpur, Malaysia.

Recent CENGILD News & Updates

Recent updates

No updates